All Eaisi articles
-
News
MHRA approves Leqembi IV maintenance as additional Alzheimerâs option
Decision provides UK Alzheimerâs patients with an alternative administration method for Eisai and Biogenâs antibody drug.
-
NewsAlzheimerâs drug milestone âbittersweetâ for certain patients
The first new dementia medicine to be licensed in over two decades shows for first time, that the course of Alzheimer disease can be modified and slow cognitive decline.